Mild depression in primary care: do antidepressants add any effect to usual consultations?

ISRCTN ISRCTN03007807
DOI https://doi.org/10.1186/ISRCTN03007807
Secondary identifying numbers NTR178; OOG00-020
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
06/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Hein Hout, van
Scientific

VU University Medical Centre
EMGO-Institute
Department of General Practice
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands

Study information

Study designMulticentre, randomised, active controlled, parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Scientific title
Study acronymHOMiD
Study objectivesAntidepressant medication does not add any effect to usual consultations by general practitioners in patients with minor and mild-major depression
Ethics approval(s)Received from local medical ethics committee
Health condition(s) or problem(s) studiedDepression
InterventionPatients were randomly assigned to four sessions of counselling during 3 months with (n=85) or without paroxetine (n=96). Both treatments were carried out by the patient’s own GP.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)paroxetine
Primary outcome measure1. Severity of Depressive by MADRS (Montgomery Åsberg Depression Rating Scale)
2. Remission of depression by MADRS score<10
Secondary outcome measures1. Quality of Live (Short Form 36)
2. Subjective depression (Beck Depression. Inventory)
3. Client Satisfaction Questionnaire
4. Direct and indirect costs
Overall study start date01/01/2002
Completion date01/05/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants181
Key inclusion criteria1. Aged 18 years or over
2. Having 3-6 out of 9 depressive symptoms for at least 2 weeks for most days of the week, including at least one of the core symptoms ‘sadness’ or ‘loss of pleasure’. Impairment by depressive symptoms in social, occupational or other important areas of functioning (minor depression=3-4 symptoms, mild-major depression=5-6 symptoms)
Key exclusion criteria1. Current intake of antidepressants or receiving psychological therapy
2. Psychotic features
3. Alcohol or drug addiction
4. Loss of a loved one or significant other in the past six months
5. Pregnancy or breastfeeding
6. Inability to complete questionnaires because of language difficulties, illiteracy or cognitive decline
7. Not having a telephone
Date of first enrolment01/01/2002
Date of final enrolment01/05/2005

Locations

Countries of recruitment

  • Netherlands

Study participating centre

VU University Medical Centre,
Amsterdam
1081 BT
Netherlands

Sponsor information

EMGO Institute (Netherlands)
Not defined

Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands

Phone +31 20 4448180
Email emgo@vumc.nl
ROR logo "ROR" https://ror.org/0258apj61

Funders

Funder type

Government

The Health Care Insurance Board (CVZ) (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 07/12/2007 Yes No